총 807페이지
804페이지 본문시작
Piddock L. J. V. Incidence and Mechanism of Ciprofloxacin Resistance in
Campylobacter spp. Isolated from Commercial Poultry Flocks in the United
Kingdombefore,during,andafterFluproquinoloneTreatment.Antimicrobial
Agents and Chemotherapy. 2005.699-707.
18. Harmon KM, Ransom GM and Wesley IV. Differentiation of Campylobacter
jejuni and Campylobacter coli by polymerase chain reaction. Mol Cell
Probes. 1997. (11):195~200
19. HumphreyT J., Jorgensen F , Jennifer A.F, WaddaH , Domingue G , Elviss
N C. , Griggs D J. , and Piddock L V. Prevalence and Subtypes of
Ciprofloxacin -Resistant Campylobacter spp. in Commercial Poultry Flocks
before,during,andafterTreatmentwithFluoroquinolones. ANTIMICROBIAL
AGENTS AND CHEMOTHERAPHY, 2005. 690-698.
20.JesseT.W.,EnglenM.D.,Pittenger-AlleyL.G.&Fedorka-CrayP.J.-Two
distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance
in Campylobacter coli and Campylobacter jejuni isolated from chickens and
beef cattle. Journal of Applied Microbiology. 2006.(100):682-688.
21.KiehlbauchJ A., HannettG E.,SalfingerM,ArchinalW, Monserrat Ce ,and
Carlyn C . Use of the National Committee for Clinical Laboratory Standards
Guidelines for Disk Diffusion Susceptibility Testing in New York State
Laboratories J. Clin. Microbiol. 2000. (38)3341-334
22.KinanaAD,CardinaleE,BahsounO,TallF,SireJM,GarinB,BoyeCS-B,
Dromigny J A, Claude JD PG. Analysis of topoisomerase mutations on
fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains
isolated in Senegal. International Journal of Antimicrobial Agents. 2007.
(29):397-401
23. Lin J, Michel L O , and Zhang Q. CmeABC Functions as a Multidrug Efflux
SysteminCampylobacterjejuni.AntimicrobialAgentsANDChemotheraphy.
2002. 2124-2131.
24.LuberP,BarteltE,GenschowE,WagnerJ,andHahnH.Comparisonofbroth
Microdilution, E Test, and Agar Dilution Methods for Antibiotic
Susceptibility Testing of Campylobacter jejuni and Campylobacter coli. J
-826-
Campylobacter spp. Isolated from Commercial Poultry Flocks in the United
Kingdombefore,during,andafterFluproquinoloneTreatment.Antimicrobial
Agents and Chemotherapy. 2005.699-707.
18. Harmon KM, Ransom GM and Wesley IV. Differentiation of Campylobacter
jejuni and Campylobacter coli by polymerase chain reaction. Mol Cell
Probes. 1997. (11):195~200
19. HumphreyT J., Jorgensen F , Jennifer A.F, WaddaH , Domingue G , Elviss
N C. , Griggs D J. , and Piddock L V. Prevalence and Subtypes of
Ciprofloxacin -Resistant Campylobacter spp. in Commercial Poultry Flocks
before,during,andafterTreatmentwithFluoroquinolones. ANTIMICROBIAL
AGENTS AND CHEMOTHERAPHY, 2005. 690-698.
20.JesseT.W.,EnglenM.D.,Pittenger-AlleyL.G.&Fedorka-CrayP.J.-Two
distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance
in Campylobacter coli and Campylobacter jejuni isolated from chickens and
beef cattle. Journal of Applied Microbiology. 2006.(100):682-688.
21.KiehlbauchJ A., HannettG E.,SalfingerM,ArchinalW, Monserrat Ce ,and
Carlyn C . Use of the National Committee for Clinical Laboratory Standards
Guidelines for Disk Diffusion Susceptibility Testing in New York State
Laboratories J. Clin. Microbiol. 2000. (38)3341-334
22.KinanaAD,CardinaleE,BahsounO,TallF,SireJM,GarinB,BoyeCS-B,
Dromigny J A, Claude JD PG. Analysis of topoisomerase mutations on
fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains
isolated in Senegal. International Journal of Antimicrobial Agents. 2007.
(29):397-401
23. Lin J, Michel L O , and Zhang Q. CmeABC Functions as a Multidrug Efflux
SysteminCampylobacterjejuni.AntimicrobialAgentsANDChemotheraphy.
2002. 2124-2131.
24.LuberP,BarteltE,GenschowE,WagnerJ,andHahnH.Comparisonofbroth
Microdilution, E Test, and Agar Dilution Methods for Antibiotic
Susceptibility Testing of Campylobacter jejuni and Campylobacter coli. J
-826-
804페이지 본문끝
메뉴
현재 포커스의 아래내용들은 동일한 컨텐츠를 가지고 페이지넘김 효과및 시각적 효과를 제공하는 페이지이므로 스크린리더 사용자는 여기까지만 낭독하시고 위의 페이지이동 링크를 사용하여 다음페이지로 이동하시기 바랍니다.